The Company
The company is a global leader in pharmaceuticals, dedicated to researching and developing innovative treatments that improve patient outcomes worldwide. It prioritizes quality assurance and testing, which are critical to maintaining regulatory compliance and ensuring product reliability and safety.
These priorities led the Quality Assurance and Testing teams to seek a more efficient testing tool. Recognizing the importance of compliance in the pharmaceutical industry, they aimed for a solution that would enhance their workflows while ensuring adherence to industry regulations.
The Challenge
The company faced significant challenges that hindered its quality assurance processes and represented risks to compliance with regulatory standards, such as:
- Manual processes: Teams were heavily reliant on Excel and Word for managing a complex document matrix, which increased the risk of errors and made it challenging to ensure compliance with industry regulations.
- Limited reporting and traceability: Generating compliance reports required cumbersome manual updates and often involved transferring information from PDFs to Word documents, which led to discrepancies and gaps in documentation, complicating regulatory audits.
- Time-consuming execution: Execution times were extended due to the absence of standardized tests and reusable test cases, creating barriers to quick responses to regulatory changes and updates.
- Lack of visibility: Achieving an overview of test campaigns was problematic, making it difficult to track actions performed by team members. This lack of traceability made it challenging to monitor adherence to protocols.
Given these challenges, the need for a more streamlined, and quality-focused tool led to their decision to adopt Xray.
The Solution
To overcome these hurdles, the company collaborated with Klee Group, an Emerging Partner for Xray based in France, to adopt Xray. Its seamless integration with Jira proved to be an advantage, and the solution was based on:
- Improved collaboration: The tool enabled real-time bug reporting, facilitating quicker resolutions and reducing miscommunication. Improved communication ensured that all actions taken during testing were thoroughly documented - allowing the company to provide evidence of meeting industry standards.
- Enhanced efficiency: Xray’s integration with JIRA maximized the utility of both platforms, allowing teams to track action histories, set precise timelines for test plans, and assess requirements and implementations quickly.
- Adaptability: The platform’s ability to share test statuses, roadmaps, and issues improved the teams’ agility. With Xray, teams became more responsive to evolving project demands while ensuring that all processes were aligned with compliance regulations. This adaptability fostered a proactive approach to testing, enabling teams to anticipate and address potential challenges before they could escalate.
By aligning quality assurance with development and business teams effectively, Xray contributed to a culture of continuous improvement that prioritized both efficiency and regulatory compliance.
The Results
The implementation of Xray transformed the company’s testing processes, leading to significant improvements in both efficiency and compliance. The measurable impact led to substantial time savings and enhanced team satisfaction.
Time efficiency:
- First test run preparation time reduced by 25%.
- Subsequent test run setups decreased by 95%.
- Test execution time was cut by 20%.
- The time taken to create bugs was reduced by 50%.
- Setup time for customized PDF reports dropped by 95%.
Increased productivity
The testing teams experienced faster release cycles and improved product quality, allowing them to focus on more strategic tasks rather than repetitive administrative duties. These improvements also ensured that compliance documentation became more reliable and easily accessible.
Overall impact
Xray enabled the pharmaceutical company to transition from a cumbersome, manual testing environment to a streamlined, efficient workflow that emphasizes both quality assurance and regulatory compliance. This shift eliminated operational inefficiencies, empowering the organization to exceed industry standards while maintaining a sharp focus on patient safety and product quality.
From manual to mastery: how Xray transformed the testing process
This global pharmaceutical company’s adoption of Xray represents more than a shift to a new testing tool; it’s a commitment to an agile, data-driven quality assurance framework that adapts to the pharmaceutical industry's evolving needs. By embracing Xray, the company has built a foundation that prioritizes immediate efficiency gains and positions its teams for long-term success. With reduced preparation times and streamlined workflows, teams can focus more on innovation and strategic initiatives that drive the business forward.
Additionally, Xray’s reporting capabilities supported the company in making data-driven decisions and continuous improvement - essential elements for enhancing operations and tackling the complexities of the pharmaceutical industry to deliver innovative treatments.
About the Partner
Klee Group, an Xray and Atlassian Platinum Partner, is committed to optimizing client processes through expert implementation, training, and continuous improvement of digital solutions. With a highly experienced team of consultants - each bringing 15 to 20 years of IT project experience. Klee Group combines deep expertise in Xray and Xporter products with agile, user-centered methods to deliver high-quality results. Rooted in values of commitment, collective intelligence, and innovation, Klee Group bridges legacy systems and modern solutions, fostering sustainable development and creating value across diverse sectors such as energy, public services, banking, and health.
